PMC6595634_01
Preoperative CT.
10.1177_2058738419859696-fig1.jpg
PMC6595634_01_10.1177_2058738419859696-fig1.jpg
fig1-2058738419859696
The patients presented no renal atrophy, renal insufficiency, or hypertension of the affected kidney during follow-up (Figures 1-5).
CT on the day of hemorrhage.
10.1177_2058738419859696-fig2.jpg
PMC6595634_01_10.1177_2058738419859696-fig2.jpg
fig2-2058738419859696
The patients presented no renal atrophy, renal insufficiency, or hypertension of the affected kidney during follow-up (Figures 1-5).
CT 2 weeks after hemorrhage.
10.1177_2058738419859696-fig3.jpg
PMC6595634_01_10.1177_2058738419859696-fig3.jpg
fig3-2058738419859696
The patients presented no renal atrophy, renal insufficiency, or hypertension of the affected kidney during follow-up (Figures 1-5).
CT after perirenal drainage.
10.1177_2058738419859696-fig4.jpg
PMC6595634_01_10.1177_2058738419859696-fig4.jpg
fig4-2058738419859696
The patients presented no renal atrophy, renal insufficiency, or hypertension of the affected kidney during follow-up (Figures 1-5).
CT after urokinase treatment.
10.1177_2058738419859696-fig5.jpg
PMC6595634_01_10.1177_2058738419859696-fig5.jpg
fig5-2058738419859696
The patients presented no renal atrophy, renal insufficiency, or hypertension of the affected kidney during follow-up (Figures 1-5).